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Abstract
Background: Tobacco use among mentally ill patients is approximately two to three times higher than that in the
general population. Withdrawal from tobacco is a common occurrence and many authors have described various
symptoms of nicotine withdrawal. Dyskinesia, however, has not been reported as one of the symptoms of nicotine
withdrawal in adolescents without any psychopathology or medical illness.
Case presentation: We report a case of a 17-year-old Motswana boy of the Tswana ethnic group with primary
school education and a 5-year history of tobacco use who developed dyskinesia approximately 48 hours after
cessation of tobacco and had some relief with nicotine gum.
Conclusion: In addition to the documented symptoms of nicotine withdrawal, clinicians should look out for
dyskinesia, which may be one of the rare symptoms of withdrawal in chronic tobacco users.
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Background
Tobacco use among mentally ill patients is approxi-
mately two to three times higher than that in the general
population [1, 2]. While some use this substance to self-
medicate symptoms of psychosis, others use it to reduce
the side effect of neuroleptics such as neuroleptic-
induced dyskinesia [1–3]. Withdrawal from tobacco is a
common occurrence, and several authors have described
various symptoms of nicotine withdrawal, such as rest-
lessness, anxiety, insomnia, dysphoria, tension, and even
delirium in the mentally ill [4–7]. Hypomania has also
been reported during nicotine cessation treatment with
bupropion [8]. Dyskinesia has not been reported as one
of the symptoms of nicotine withdrawal, especially in
unmedicated adolescents without any psychopathology
or medical illness to the best of the authors’ knowledge,
hence the need to report this case.
Case presentation
A 17-year-old Motswana boy of the Tswana ethnic group
with a primary school education was brought to our
psychiatric hospital with a 5-year history of tobacco smok-
ing and delinquent behaviors. He is the first in a family of
three children; both his parents are alive but separated.
He lives with his mother who is of low socioeconomic sta-
tus; she has a busy schedule and works full time. There is
no history of mental illness or substance abuse in the fam-
ily. He was observed at the age of 11 years to exhibit con-
duct disorder behaviors such as disobedience, stealing,
truancy, and hanging out with “street kids.” He was first
introduced to tobacco smoking by his friends at age 12
years. He started with a Peter Stuyvesant (nicotine content
of 1.3 mg/cigarette) brand of cigarette which was initially
unpleasant; however, he continued with persuasion from
his friends. He gradually stepped up his use from one
cigarette/day over the next 2 to 3 years to approximately
20 to 30 cigarettes per day to sustain the relaxing and
stimulating effect which improved his daily performance.
He admitted to craving for this substance to the extent of
doing dirty jobs for people to sustain the habit and
neglecting other previous forms of enjoyment, such as
watching television with family members. He has had
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several unsuccessful attempts at controlling the amount
he took in a day despite the knowledge of its harmful con-
sequences. His longest period of abstinence was 3 months
in a rehabilitation center which was approximately 3.5
years ago. He had once experimented with cannabis and
alcohol, but he never enjoyed these substances and so did
not continue.
Two months prior to his index presentation at our
hospital, he progressively neglected his personal hygiene
and food, became emaciated, and spent more time
cigarette smoking (that is, smoking continuously); he
decided to seek medical attention at this time.
There were no psychotic symptoms on admission, but
he was very restless, irritable, and had intense craving
for this substance. In addition he complained of head-
ache and insomnia.
He has had no previous treatment or admission for any
psychological disorder and was never on any psychotropic
medication before his index presentation at our hospital. A
year after he started smoking cigarettes, his mother decided
to seek spiritual help when he was observed to be smoking
cigarettes at the expense of other activities, pilfering, and
playing truant, but there was no significant improvement.
His cigarette smoking subsequently became excessive over
the next 6 months and he consequently started neglecting
his personal hygiene, withdrawing from family activities,
and preferring to smoke cigarettes rather than eat; thus, he
was becoming emaciated. As a result, his mother was
advised to try a rehabilitation center. He spent 3 months in
a rehabilitation center 3 years prior to his presenting at our
hospital. He went through drug education, counselling,
and was abstinent for only this period. He had neither
psychotic nor mood symptoms before or during the period
of rehabilitation, and did not experience any abnormal
movement. He only complained of restlessness and ten-
sion; nevertheless, he was not placed on any medication
other than multivitamins. While he was in the rehabilita-
tion center, he was completely abstinent and his appetite
and weight improved considerably. On leaving the rehabili-
tation center, he attended follow-up only once before he
defaulted. Afterwards, he went back to smoking cigarettes
and has had no period of abstinence until his index admis-
sion to our mental health facility.
Before he started smoking cigarettes, he was described
as an easy child, quite cheerful, and an outgoing person
who enjoyed the company of other children.
A mental state examination at his index admission to
our hospital revealed agitation, but there was no abnor-
mality of speech, thought, or perception. He described
his mood as fine, but objectively it was anxious.
A physical examination revealed no significant abnor-
mality. His blood pressure was 110/70 mmHg, pulse rate
was 90 beats/minute, and his temperature was 37 °C.
Investigations such as full blood count, liver function
test, thyroid function test, as well as computed tomog-
raphy (CT) scanning of his brain revealed no significant
abnormality. Urine drug screening was negative for
substances which included cannabis, cocaine, and phen-
cyclidine, except for benzodiazepines, which was given
to reduce restlessness and to improve sleep.
The working diagnosis made was mental and behav-
ioral disorder due to psychoactive substance use; nico-
tine dependence with comorbid conduct disorder.
Three days postadmission, he was observed to be
having some abnormal involuntary movement such as
occasional chewing movements, trunk twisting, and
truncal tremor. During an interview he tried to conceal
the involuntary movements of his hands by holding his
chair with a firm grip. According to the nurses’ reports,
these movements often disappeared during sleep and
briefly whenever his attention was called to them. He
admitted to the fact that he first experienced these
movements approximately 2 years ago and has also
observed their disappearance whenever he smokes. This
claim was supported following some relief which he ex-
perienced with nicotine gum (Nicorette); an offer which
he previously refused.
He was on admission for 4 weeks with scheduled
sessions with a psychologist on drug counselling and
education. In addition he was placed on diazepam 10 mg
on the first night and twice daily for 5 days in addition
to nicotine gum which was made available to him on
demand.
His level of hygiene as well as his appetite improved
approximately 2 weeks after admission in response to
therapy. In addition, his abnormal movements reduced
after 3 weeks on nicotine gum after which he was dis-
charged home with the gum. He was to continue with
monthly psychological sessions on an out-patient basis
since there was no formal rehabilitation program in the
facility. He was seen only once on follow-up during
which it was noted that he did well on nicotine gum
without any adverse effect. His appetite, level of hygiene,
and weight were also well maintained but he then
defaulted.
Discussion
Here we report a case of an unmedicated young man
with chronic use of tobacco who developed dyskinesia
approximately 48 hours after cessation of tobacco and
had some relief with nicotine gum. The fact that he first
experienced these abnormal movements approximately 2
years ago following tobacco cessation or reduction in his
level of use and had been self-medicating with cigarettes
suggests it had become a chronic condition.
It has been shown that nicotine increases striatal and
cortical dopamine release in patients with schizophrenia
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[9]; hence, the suggestion that nicotine-induced cogni-
tive enhancement and locomotor stimulation is
dependent on dopamine release [9, 10]. With chronic
exposure to nicotine, tolerance ensues leading to a
reduction in the effect of nicotine, and eventually a de-
crease in dopamine release [11]. This may partly explain
the increase in the level of use in order to sustain its
cognitive-enhancing effect, even among non-psychiatric
users, thus explaining one of the reasons why our index
patient has been unable to stop smoking cigarettes. In
addition, dyskinesia of various kinds have been exten-
sively reported among psychiatric patients on anti-
psychotic treatments, due to the blockade of dopamine
activities [4] and, so, dyskinesia may result consequent
to a sudden reduction in nicotine use among chronic
users. Dyskinesia may therefore be one of the symptoms
of withdrawal in the same way that a prolonged blockade
of dopamine at the dorsal striatum by antipsychotic
medication causes dyskinesia. This unpleasant side effect
may be another reason why it had been very difficult for
him to stop tobacco use in addition to its cognitive-
enhancing effect.
Limitation
Our inability to monitor his blood nicotine level due to
the unavailability of facilities limits our ability to correl-
ate his blood nicotine level with the development and
severity of his symptom (that is, dyskinesia).
Conclusions
In addition to losing the cognitive-enhancing effect of
cigarette smoking and experiencing common withdrawal
effects such as restlessness, tension, and delirium, dys-
kinesia, which we have reported as a dreadful effect of
withdrawal, may be one of the unexplored or very rare
reasons why many chronic cigarette smokers find it diffi-
cult to stop the habit.
Clinicians should look out for a history of dyskinesia
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